VeriMomVeriMom
HIGH RISK

임신 중 sodium picramate을 피해야 할까요? | VeriMom

Harmonised classification for sodium picramate/picramic acid includes Repr. 1B H360F (“May damage fertility”) in ECHA/CLP-related registrations and dossiers; per your calibration H360→h=3. SCCS has evaluated picramic acid/sodium picramate for hair-dye use and set restricted maximum on-head concentration (0.6% in non-oxidative hair dyes), indicating systemic/repro concern driving the restriction. Evidence for a specific molecular reproductive mechanism is limited in available reviews (so m=1). Topical hair-dye use can lead to low but measurable systemic exposure in adults (SCCS restriction), so e=1.

ECHA regulatory hazard statements

  • H360F

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

sodium picramate은 임신 중 안전한가요?
Harmonised classification for sodium picramate/picramic acid includes Repr. 1B H360F (“May damage fertility”) in ECHA/CLP-related registrations and dossiers; per your calibration H360→h=3. SCCS has evaluated picramic acid/sodium picramate for hair-dye use and set restricted maximum on-head concentration (0.6% in non-oxidative hair dyes), indicating systemic/repro concern driving the restriction. Evidence for a specific molecular reproductive mechanism is limited in available reviews (so m=1). Topical hair-dye use can lead to low but measurable systemic exposure in adults (SCCS restriction), so e=1.
sodium picramate은 모유 수유 중 안전한가요?
Harmonised classification (H360F) applies regardless of exposure route; therefore h=3. No robust data were located demonstrating mechanism or mammary‑transfer studies (m=1). Given likely limited systemic absorption from typical topical hair‑dye use but non-zero (SCCS restriction), maternal systemic exposure — and therefore potential, low breast‑milk exposure — is possible (e=1).
sodium picramate은 아기 피부에 안전한가요?
Hazard (H360F) remains the relevant intrinsic property so h=3 (do not up‑rank hazard without infant‑specific evidence). Mechanistic evidence for a reproductive pathway is limited (m=1). Because infant skin has higher absorption per weight and immature barrier, and adult topical use shows measurable absorption, increase exposure by +1 for 0–3 yr (adult e=1 → baby e=2). No infant‑specific toxicokinetic or dermal absorption studies were found.
VeriMom은 sodium picramate을 어떻게 평가하나요?
VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 sodium picramate을 27/100 (높은 위험)로 평가합니다.
임신 중 sodium picramate 대체 안전 성분은?
유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.

모든 성분표를 2초 만에 확인

VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.

의료 면책 조항

이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.

VeriMom 앱에서 모든 기능을 이용해 보세요